Showing 1 - 12 results of 12 for search 'E. S. Kropacheva', query time: 0.02s Refine Results
  1. 1
    SAFETY ISSUES IN THE TREATMENT OF PATIENTS TAKING DABIGATRAN

    SAFETY ISSUES IN THE TREATMENT OF PATIENTS TAKING DABIGATRAN by E. S. Kropacheva

    Published 2016-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    SAFETY OF THERAPY AND PATRONAGE SYSTEM IN PATIENTS WHO RECEIVE WARFARIN

    SAFETY OF THERAPY AND PATRONAGE SYSTEM IN PATIENTS WHO RECEIVE WARFARIN by E. S. Kropacheva

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment

    Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment by E. S. Kropacheva

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS

    SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS by E. S. Kropacheva

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations

    The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations by E. S. Kropacheva, E. P. Panchenko

    Published 2023-08-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY)

    CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY) by E. S. Kropacheva, O. A. Zemlyanskaya, A. В. Dobrovolsky, Е. P. Panchenko

    Published 2018-05-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a prospective 10-year follow-up study)

    THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a pr... by E. S. KROPACHEVA, O. A. ZEMLYANSKAYA, A. B. DOBROVOLSKY, E. P. PANCHENKO

    Published 2017-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)

    SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up) by E. S. Kropacheva, O. A. Zemlyanskaya, E. P. Panchenko, A. B. Dobrovolsky, E. N. Krivosheeva

    Published 2017-05-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants

    Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants by A. I. Mironova, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention

    Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention by E. N. Krivosheeva, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

    Published 2021-08-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION

    EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION by S. P. Golitsyn, E. P. Panchenko, E. S. Kropacheva, L. Yu. Layovich, E. B. Maikov, N. Yu. Mironov, O. O. Shakhmatova

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    2020 Clinical guidelines for Atrial fibrillation and atrial flutter

    2020 Clinical guidelines for Atrial fibrillation and atrial flutter by M. G. Arakelyan, L. A. Bockeria, E. Yu. Vasilieva, S. P. Golitsyn, E. Z. Golukhova, M. V. Gorev, K. V. Davtyan, O. M. Drapkina, E. S. Kropacheva, E. A. Kuchinskaya, L. Yu. Lajovich, N. Yu. Mironov, I. E. Mishina, E. P. Panchenko, A. Sh. Revishvili, F. G. Rzayev, B. A. Tatarsky, M. D. Utsumueva, O. O. Shakhmatova, N. B. Shlevkov, A. V. Shpektor, D. A. Andreev, E. A. Artyukhina, O. L. Barbarash, A. S. Galyavich, D. V. Duplyakov, S. A. Zenin, D. S. Lebedev, E. N. Mikhailov, N. A. Novikova, S. V. Popov, A. G. Filatov, E. V. Shlyakhto, Yu. V. Shubik

    Published 2021-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: